Cranbrook Wealth Management, LLC Alkermes Plc. Transaction History
Cranbrook Wealth Management, LLC
- $431 Million
- Q4 2024
A detailed history of Cranbrook Wealth Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Cranbrook Wealth Management, LLC holds 44 shares of ALKS stock, worth $1,474. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44
Previous 44
-0.0%
Holding current value
$1,474
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
365Shares Held
176MCall Options Held
166KPut Options Held
118K-
Black Rock Inc. New York, NY29.1MShares$975 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$620 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$435 Million0.04% of portfolio
-
State Street Corp Boston, MA9.19MShares$308 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.01MShares$235 Million0.04% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.5B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...